The Natural Chemotherapeutics Research Institute is one of the beneficiaries of an investment by The Presidential Scientific Initiative on Epidemics (PRESIDE), into research studies to evaluate therapeutics that have potential to contribute to the fight of the SARS-COV-2 (COVID-19) pandemic.